Valuation : Molecure S.A.

Market Cap 133M 35.67M 30.69M 28.8M 26.35M 49.18M 3.37B 49.57M 341M 1.72B 134M 131M 5.55B P/E 2025 *
-
P/E 2026 * -
Enterprise Value 102M 27.36M 23.54M 22.09M 20.21M 37.73M 2.59B 38.03M 261M 1.32B 103M 101M 4.26B EV / Sales 2025
19.2x
EV / Sales 2026 * 65.8x
Free-Float
70.71%
Yield 2025 *
-
Yield 2026 * -
1 day+0.63%
1 week+4.89%
Current month+5.57%
1 month+5.40%
3 months+7.87%
6 months-14.81%
Current year-2.42%
1 week 5.95
Extreme 5.95
6.49
1 month 5.82
Extreme 5.82
6.49
Current year 4.98
Extreme 4.98
9.04
1 year 4.98
Extreme 4.98
9.04
3 years 4.98
Extreme 4.98
22.95
5 years 4.98
Extreme 4.98
47.5
10 years 4.98
Extreme 4.98
80.4
Manager TitleAgeSince
Chief Executive Officer - 01/12/2012
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - 03/01/2023
Director TitleAgeSince
Director/Board Member - 30/06/2021
Chairman 38 01/06/2023
Director/Board Member - 14/01/2022
Date Insider Type Main position Quantity % Market Cap. Importance
22/12/23 Buy

Chief Executive Officer

49,000 0.2910%
Change 5-day change 1-year change 3-year change Capi.($)
+0.62%+4.89%-15.04%-70.05% 35.31M
+0.41%-1.65%+39.85%+95.40% 68.87B
+1.31%+1.65%+50.56%+90.80% 65.29B
+0.04%+1.84%-12.81%+459.54% 27.65B
+2.97%-0.10%+41.86%+14.84% 25.77B
-0.90%-8.60%+2.25%-15.50% 26.08B
+1.01%+1.76%+32.99%-17.16% 20.14B
+3.45%-14.83%+225.22%+389.50% 17.03B
+0.77%-4.55%-0.36%+549.41% 15.03B
+1.03%+5.40%+59.04%+160.03% 14.5B
Average +1.02%-1.77%+42.35%+165.68% 28.04B
Weighted average by Cap. +0.92%-1.63%+43.43%+149.95%

Financials

2025 2026 *
Net sales 3.9M 1.05M 902K 847K 775K 1.45M 99.11M 1.46M 10.01M 50.65M 3.94M 3.85M 163M 2M 538K 463K 434K 397K 741K 50.83M 747K 5.14M 25.97M 2.02M 1.98M 83.65M
Net income -21.2M -5.7M -4.9M -4.6M -4.21M -7.86M -539M -7.92M -54.44M -275M -21.4M -20.94M -887M -13M -3.49M -3.01M -2.82M -2.58M -4.82M -330M -4.86M -33.38M -169M -13.12M -12.84M -544M
Net Debt -30.9M -8.31M -7.15M -6.71M -6.14M -11.45M -785M -11.54M -79.34M -401M -31.19M -30.51M -1.29B -1M -269K -231K -217K -199K -371K -25.41M -374K -2.57M -12.99M -1.01M -988K -41.83M
Logo Molecure S.A.
Molecure SA, formerly known as Oncoarendi Therapeutics SA, is a Poland-based biopharmaceutical company. The Company is dedicated to discovering, developing and commercializing therapeutics for neoplastic and inflammatory diseases. The Company's business model is focused on drug discovery and development, with its core strength in medicinal chemistry and preclinical biology, enhanced by scientific collaborations in specific disease areas. The Company has a platform of 3 distinct small molecule programs targeting chitinases hydrolytic enzymes with potential utility in diverse inflammatory and fibrotic diseases of high unmet medical need. Additionally, it has initiated a program focused on development of small molecule immune modulators to stop the ability of tumors to escape immune surveillance.
Employees
71
Date Price Change Volume
03/09/26 PLN 6.440 +0.62% 45,684
02/09/26 PLN 6.400 +4.75% 116,634
01/09/26 PLN 6.110 +0.16% 39,337
31/08/26 PLN 6.100 +0.83% 19,531
28/08/26 PLN 6.050 -1.14% 35,957
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
6.400PLN
Average target price
12.45PLN
Spread / Average Target
+94.53%

Quarterly revenue - Rate of surprise